Integrated Proteomic and Metabolic Analysis of Breast Cancer Progression

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Shaw, Patrick G ^a,c   Chaerkady, Raghothama ^d   Wang, Tao ^a,b   Vasilatos, Shauna ^a,b   Huang, Yi ^a,b   Van Houten, Bennett ^a,b   Pandey, Akhilesh ^d   Davidson, Nancy E ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; LACTIC ACID; MULTIENZYME COMPLEX; ONCOPROTEIN; PYRUVIC ACID; RAS PROTEIN;

ACIDIFICATION; AMINO ACID METABOLISM; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GRADING; CANCER GROWTH; CELL FRACTIONATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE DOSAGE; GLYCOLYSIS; ISOTOPE LABELING; METABOLIC CAPACITY; METABOLIC RATE; MOLECULAR PROBE; OXIDATIVE PHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEOMICS; QUANTITATIVE ANALYSIS;

BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMATOGRAPHY, LIQUID; DISEASE PROGRESSION; ENZYMES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; ISOTOPE LABELING; METABOLOMICS; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; ORGANELLES; OXIDATIVE PHOSPHORYLATION; PROTEOMICS; SUBCELLULAR FRACTIONS; TANDEM MASS SPECTROMETRY;

EID: 84884686363     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076220     Document Type: Article

References (41)

1. Soule HD, Maloney TM, Wolman SR, Peterson WD Jr., Brenz R, et al. (1990) Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 50: 6075-6086. PubMed: 1975513.
2. Dawson PJ, Wolman SR, Tait L, Heppner GH, Miller FR, (1996) MCF10AT: a model for the evolution of cancer from proliferative breast disease. Am J Pathol 148: 313-319. PubMed: 8546221.
3. Santner SJ, Dawson PJ, Tait L, Soule HD, Eliason J, et al. (2001) Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells. Breast Cancer Res Treat 65: 101-110. doi:10.1023/A:1006461422273. PubMed: 11261825.
4. Worsham MJ, Pals G, Schouten JP, Miller F, Tiwari N, et al. (2006) High-resolution mapping of molecular events associated with immortalization, transformation, and progression to breast cancer in the MCF10 model. Breast Cancer Res Treat 96: 177-186. doi:10.1007/s10549-005-9077-8. PubMed: 16319984.
5. Kadota M, Yang HH, Gomez B, Sato M, Clifford RJ, et al. (2010) Delineating genetic alterations for tumor progression in the MCF10A series of breast cancer cell lines. PLOS ONE 5: e9201. doi:10.1371/journal.pone.0009201. PubMed: 20169162.
6. Moelans CB, de Weger RA, Monsuur HN, Vijzelaar R, van Diest PJ, (2010) Molecular profiling of invasive breast cancer by multiplex ligation-dependent probe amplification-based copy number analysis of tumor suppressor and oncogenes. Mod Pathol 23: 1029-1039. doi:10.1038/modpathol.2010.84. PubMed: 20473280.
7. Marella NV, Malyavantham KS, Wang J, Matsui S, Liang P, et al. (2009) Cytogenetic and cDNA microarray expression analysis of MCF10 human breast cancer progression cell lines. Cancer Res 69: 5946-5953. doi:10.1158/0008-5472.CAN-09-0420. PubMed: 19584277.
8. Kim SH, Miller FR, Tait L, Zheng J, Novak RF, (2009) Proteomic and phosphoproteomic alterations in benign, premalignant and tumor human breast epithelial cells and xenograft lesions: biomarkers of progression. Int J Cancer 124: 2813-2828. doi:10.1002/ijc.24278. PubMed: 19291795.
9. Buchanan NS, Zhao J, Zhu K, Patwa TH, Miller FR, et al. (2007) Differential expression of acidic proteins with progression in the MCF10 model of human breast disease. Int J Oncol 31: 941-949. PubMed: 17786328.
10. Lim S, Choong LY, Kuan CP, Yunhao C, Lim YP, (2009) Regulation of macrophage inhibitory factor (MIF) by epidermal growth factor receptor (EGFR) in the MCF10AT model of breast cancer progression. J Proteome Res 8: 4062-4076. doi:10.1021/pr900430n. PubMed: 19530702.
11. Choong LY, Lim S, Chong PK, Wong CY, Shah N, et al. (2010) Proteome-wide profiling of the MCF10AT breast cancer progression model. PLOS ONE 5: e11030. doi:10.1371/journal.pone.0011030. PubMed: 20543960.
12. Warburg O, (1956) On respiratory impairment in cancer cells. Science 124: 269-270. PubMed: 13351639.
13. Yang D, Wang MT, Tang Y, Chen Y, Jiang H, et al. (2010) Impairment of mitochondrial respiration in mouse fibroblasts by oncogenic H-RAS(pp. Q61L). Cancer Biol Ther 9: 122-133.
14. Debnath J, Muthuswamy SK, Brugge JS, (2003) Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30: 256-268. doi:10.1016/S1046-2023(03)00032-X. PubMed: 12798140.
15. Harsha HC, Molina H, Pandey A, (2008) Quantitative proteomics using stable isotope labeling with amino acids in cell culture. Nat Protoc 3: 505-516. doi:10.1038/nprot.2008.2. PubMed: 18323819.
16. Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, et al. (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1: 376-386. doi:10.1074/mcp.M200025-MCP200. PubMed: 12118079.
17. Cox B, Emili A, (2006) Tissue subcellular fractionation and protein extraction for use in mass-spectrometry-based proteomics. Nat Protoc 1: 1872-1878. doi:10.1038/nprot.2006.273. PubMed: 17487171.
18. Olsen JV, de Godoy LM, Li G, Macek B, Mortensen P, et al. (2005) Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap. Mol Cell Proteomics 4: 2010-2021. doi:10.1074/mcp.T500030-MCP200. PubMed: 16249172.
19. Huang W, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57. PubMed: 19131956.
20. Huang W, Sherman BT, Lempicki RA, (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37: 1-13. doi:10.1093/nar/gkp505. PubMed: 19033363.
21. Qian W, Van Houten B, (2010) Alterations in bioenergetics due to changes in mitochondrial DNA copy number. Methods 51: 452-457. doi:10.1016/j.ymeth.2010.03.006. PubMed: 20347038.
22. Blagoev B, Ong SE, Kratchmarova I, Mann M, (2004) Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics. Nat Biotechnol 22: 1139-1145. doi:10.1038/nbt1005. PubMed: 15314609.
23. Shen J, Platek M, Mahasneh A, Ambrosone CB, Zhao H, (2010) Mitochondrial copy number and risk of breast cancer: a pilot study. Mitochondrion 10: 62-68. doi:10.1016/j.mito.2009.09.004. PubMed: 19788937.
24. Nieminen AL, Saylor AK, Herman B, Lemasters JJ, (1994) ATP depletion rather than mitochondrial depolarization mediates hepatocyte killing after metabolic inhibition. Am J Physiol 267: C67-C74. PubMed: 8048493.
25. Wang JB, Sonn R, Tekletsadik YK, Samorodnitsky D, Osman MA, (2009) IQGAP1 regulates cell proliferation through a novel CDC42-mTOR pathway. J Cell Sci 122: 2024-2033. doi:10.1242/jcs.044644. PubMed: 19454477.
26. Heasman SJ, Ridley AJ, (2008) Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat Rev Mol Cell Biol 9: 690-701. doi:10.1038/nrm2476. PubMed: 18719708.
27. Semenza GL, (2007) HIF-1 mediates the Warburg effect in clear cell renal carcinoma. J Bioenerg Biomembr 39: 231-234. doi:10.1007/s10863-007-9081-2. PubMed: 17551816.
28. Dewhirst MW, Cao Y, Moeller B, (2008) Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat Rev Cancer 8: 425-437. doi:10.1038/nrc2397. PubMed: 18500244.
29. Lee JJ, Natsuizaka M, Ohashi S, Wong GS, Takaoka M, et al. (2010) Hypoxia activates the cyclooxygenase-2-prostaglandin E synthase axis. Carcinogenesis 31: 427-434. doi:10.1093/carcin/bgp326. PubMed: 20042640.
30. Hansen WJ, Ohh M, Moslehi J, Kondo K, Kaelin WG, et al. (2002) Diverse effects of mutations in exon II of the von Hippel-Lindau (VHL) tumor suppressor gene on the interaction of pVHL with the cytosolic chaperonin and pVHL-dependent ubiquitin ligase activity. Mol Cell Biol 22: 1947-1960. doi:10.1128/MCB.22.6.1947-1960.2002. PubMed: 11865071.
31. Liu YV, Semenza GL, (2007) RACK1 vs. HSP90: Competition for HIF-1 alpha degradation vs. stabilization. Cell Cycle 6: 656-659. doi:10.4161/cc.6.6.3981. PubMed: 17361105.
32. Caswell PT, Vadrevu S, Norman JC, (2009) Integrins: masters and slaves of endocytic transport. Nat Rev Mol Cell Biol 10: 843-853. doi:10.1038/nrm2799. PubMed: 19904298.
33. Braschi E, Goyon V, Zunino R, Mohanty A, Xu L, et al. (2010) Vps35 mediates vesicle transport between the mitochondria and peroxisomes. Curr Biol 20: 1310-1315. doi:10.1016/j.cub.2010.05.066. PubMed: 20619655.
34. Samudio I, Fiegl M, Andreeff M, (2009) Mitochondrial uncoupling and the Warburg effect: molecular basis for the reprogramming of cancer cell metabolism. Cancer Res 69: 2163-2166. doi:10.1158/0008-5472.SABCS-09-2163. PubMed: 19258498.
35. Bayley JP, Devilee P, (2010) Warburg tumours and the mechanisms of mitochondrial tumour suppressor genes. Barking up the right tree? Curr Opin Genet Dev 20: 324-329. doi:10.1016/j.gde.2010.02.008. PubMed: 20304625.
36. Levine AJ, Puzio-Kuter AM, (2010) The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 330: 1340-1344. doi:10.1126/science.1193494. PubMed: 21127244.
37. von Lintig FC, Dreilinger AD, Varki NM, Wallace AM, Casteel DE, et al. (2000) Ras activation in human breast cancer. Breast Cancer Res Treat 62: 51-62. doi:10.1023/A:1006491619920. PubMed: 10989985.
38. Yagoda N, von Rechenberg M, Zaganjor E, Bauer AJ, Yang WS, et al. (2007) RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature 447: 864-868. PubMed: 17568748.
39. Sonveaux P, Végran F, Schroeder T, Wergin MC, Verrax J, et al. (2008) Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest 118: 3930-3942. PubMed: 19033663.
40. Le Floch R, Chiche J, Marchiq I, Naiken T, Ilc K, et al. (2011) CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors. Proc Natl Acad Sci U S A 108: 16663-16668. doi:10.1073/pnas.1106123108. PubMed: 21930917.
41. Sun C, Liu X, Qi L, Xu J, Zhao J, et al. (2010) Modulation of vascular endothelial cell senescence by integrin β4. J Cell Physiol 225: 673-681. doi:10.1002/jcp.22262. PubMed: 20509141.